Specialized Diagnostic Investigations to Assess Ocular Status in Hypertensive Diseases of Pregnancy

Overview

Journal Diseases

Date 2017 Sep 22

PMID 28933399

Citations 2

Authors

Rahul Navinchandra Bakhda

Affiliations

Soon will be listed here.

Abstract

This review describes specialized diagnostic investigations to assess ocular status in hypertensive diseases of pregnancy. Ocular assessment can aid in early detection for prompt multidisciplinary treatment, obstetric intervention and follow-up. The investigations accurately predict the possible causes of blindness in hypertensive diseases of pregnancy. The investigations include fluorescein angiography, ophthalmodynamometry, fluorophotometry, imaging modalities, OCT, ultrasonography, doppler velocimetry and blood chemistry analysis. The review includes a summary of imaging techniques and related recent developments to assess the neuro-ophthalmic aspects of the disease. The imaging modalities have been instrumental in understanding the complex neuropathophysiological mechanisms of eclamptic seizures. The importance of blood chemistry analysis in hypertensive diseases of pregnancy has been emphasized. The investigations have made a significant contribution in improving the standards of antenatal care and reducing maternal and fetal morbidity and mortality.

Citing Articles

Current Trends in Diagnosis and Treatment Approach of Diabetic Retinopathy during Pregnancy: A Narrative Review.

Rosu L, Prodan-Barbulescu C, Maghiari A, Bernad E, Bernad R, Iacob R Diagnostics (Basel). 2024; 14(4).

PMID: 38396408 PMC: 10887682. DOI: 10.3390/diagnostics14040369.

Case-control study on ocular changes and ophthalmic Doppler velocimetric indices among preeclamptic and normotensive pregnant women in Ibadan, Nigeria.

Onwudiegwu C, Adekanmi A, Olusanya B, Lawal O, Adedokun B, Morhason-Bello I BMJ Open Ophthalmol. 2020; 5(1):e000550.

PMID: 32984544 PMC: 7488785. DOI: 10.1136/bmjophth-2020-000550.

References

Goldman J . New techniques and applications for magnetic resonance angiography. Mt Sinai J Med. 2003; 70(6):375-85. View

Thomas S, Somanathan N, Radhakumari R . Interictal EEG changes in eclampsia. Electroencephalogr Clin Neurophysiol. 1995; 94(4):271-5. DOI: 10.1016/0013-4694(95)98478-q. View

Lau S, Chan F, Yu Y, Woo E, Huang C . Cortical blindness in toxaemia of pregnancy: findings on computed tomography. Br J Radiol. 1987; 60(712):347-9. DOI: 10.1259/0007-1285-60-712-347. View

Arakia Y, Ashikaga R, Fujii K, Nishimura Y, Ueda J, Fujita N . MR fluid-attenuated inversion recovery imaging as routine brain T2-weighted imaging. Eur J Radiol. 2000; 32(2):136-43. DOI: 10.1016/s0720-048x(98)00158-2. View

Delfaut E, Beltran J, Johnson G, Rousseau J, Marchandise X, Cotten A . Fat suppression in MR imaging: techniques and pitfalls. Radiographics. 1999; 19(2):373-82. DOI: 10.1148/radiographics.19.2.g99mr03373. View

Firsching R, Muller C, Pauli S, Voellger B, Rohl F, Behrens-Baumann W . Noninvasive assessment of intracranial pressure with venous ophthalmodynamometry. Clinical article. J Neurosurg. 2011; 115(2):371-4. DOI: 10.3171/2011.3.JNS101275. View

Kwok A, Li J, Lai T, Chan W, Bhende P, Lam D . Multifocal electroretinographic and angiographic changes in pre-eclampsia. Br J Ophthalmol. 2001; 85(1):111-2. PMC: 1723698. DOI: 10.1136/bjo.85.1.110a. View

Kayazawa F, Miyake K . Ocular fluorophotometry in patients with essential hypertension. Arch Ophthalmol. 1984; 102(8):1169-70. DOI: 10.1001/archopht.1984.01040030947020. View

Lee A, Hayman L, Ross A . Neuroimaging contrast agents in ophthalmology. Surv Ophthalmol. 2000; 45(3):237-53. DOI: 10.1016/s0039-6257(00)00152-1. View

10.

Resnik J, Hong C, Resnik R, Kazanegra R, Beede J, Bhalla V . Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. Am J Obstet Gynecol. 2005; 193(2):450-4. DOI: 10.1016/j.ajog.2004.12.006. View

11.

Kocyigit Y, Atamer Y, Atamer A, Tuzcu A, Akkus Z . Changes in serum levels of leptin, cytokines and lipoprotein in pre-eclamptic and normotensive pregnant women. Gynecol Endocrinol. 2005; 19(5):267-73. DOI: 10.1080/09513590400018108. View

12.

Stodtmeister R, Oppitz T, Spoerl E, Haustein M, Boehm A . Contact lens dynamometry: the influence of age. Invest Ophthalmol Vis Sci. 2010; 51(12):6620-4. DOI: 10.1167/iovs.09-4594. View

13.

Dahmus M, Barton J, Sibai B . Cerebral imaging in eclampsia: magnetic resonance imaging versus computed tomography. Am J Obstet Gynecol. 1992; 167(4 Pt 1):935-41. DOI: 10.1016/s0002-9378(12)80015-9. View

14.

Gregory D, Pelak V, Bennett J . Diffusion-weighted magnetic resonance imaging and the evaluation of cortical blindness in preeclampsia. Surv Ophthalmol. 2003; 48(6):647-50. DOI: 10.1016/j.survophthal.2003.08.008. View

15.

Citirik M, Simsek T, Zilelioglu O . Bilateral permanent concentric visual field defect secondary to severe pre-eclampsia. Clin Ophthalmol. 2009; 2(2):465-8. PMC: 2693965. DOI: 10.2147/opth.s2360. View

16.

Leitgeb R, Hitzenberger C, Fercher A . Performance of fourier domain vs. time domain optical coherence tomography. Opt Express. 2009; 11(8):889-94. DOI: 10.1364/oe.11.000889. View

17.

Voto L, Illia R, IMAZ F, Margulies M . Uric acid levels: a useful index of the severity of preeclampsia and perinatal prognosis. J Perinat Med. 1988; 16(2):123-6. DOI: 10.1515/jpme.1988.16.2.123. View

18.

Vander Werff T . The pressure measured in ophthalmodynamometry. Arch Ophthalmol. 1972; 87(3):290-2. DOI: 10.1001/archopht.1972.01000020292011. View

19.

Perednia D, Allen A . Telemedicine technology and clinical applications. JAMA. 1995; 273(6):483-8. View

20.

Chaine G, Attali P, Gaudric A, Colin M, Quentel G, Coscas G . Ocular fluorophotometric and angiographic findings in toxemia of pregnancy. Arch Ophthalmol. 1986; 104(11):1632-5. DOI: 10.1001/archopht.1986.01050230070035. View